Is the translational approach becoming a reality in nanomedicine?: The key points of the 2nd translational nanomedicine conference, Angers, August 2014

European Journal of Nanomedicine

Volumn 7, Issue 2, 2015, Pages 79-83

  Malhaire, Hélène ^a,b   Lagarce, Frederic ^a,b,c  

^a UNIVERSITÉ D'ANGERS   (France)

^b UNIVERSITÉ D'ANGERS   (France)

^c ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

clinics; nanomedicine; pharmaceutical industry; translational research

Indexed keywords

INDUSTRIAL RESEARCH;

CLINICS; COLLABORATIVE RESEARCH; GREEN NANOTECHNOLOGIES; INTERDISCIPLINARY WORK; LARGE SCALE PRODUCTIONS; PHARMACEUTICAL COMPANY; PHARMACEUTICAL INDUSTRY; TRANSLATIONAL RESEARCH;

MEDICAL NANOTECHNOLOGY;

BACTERIOPHAGE ASSOCIATED SILICON PARTICLE; SILICA NANOPARTICLE; UNCLASSIFIED DRUG;

ARTICLE; CANCER THERAPY; DRUG APPROVAL; DRUG DELIVERY SYSTEM; DRUG INDUSTRY; FOLLOW UP; HUMAN; IN VITRO STUDY; NANOMEDICINE; NANOTECHNOLOGY; NONHUMAN; PHASE 3 CLINICAL TRIAL (TOPIC); SPRAY DRYING; SUPERCRITICAL FLUID; SUPERCRITICAL FLUID EXTRACTION;

EID: 84927935335     PISSN: 16625986     EISSN: 1662596X     Source Type: Journal    
DOI: 10.1515/ejnm-2014-0045     Document Type: Article

References (19)

1. Cancer Facts and Statistics. American Cancer Society [Internet]. [cited 2014 Nov 6]. Available from: http://www.cancer.org/research/cancerfactsstatistics/index.
2. Przystal JM, Umukoro E, Stoneham CA, Yata T, O'Neill K, Syed N, et al. Proteasome inhibition in cancer is associated with enhanced tumor targeting by the adeno-associated virus/phage. Mol Oncol. 2013;7:55-66.
3. Yuan Z, Pastoriza J, Quinn T, Libutti SK. Chapter 2 - Targeting Tumor Vasculature Using Adeno-Associated Virus Phage Vectors Coding Tumor Necrosis Factor-α. In: Gerson ECLL, editor. Gene Therapy of Cancer (Third Edition) [Internet]. San Diego: Academic Press; 2014 [cited 2014 Oct 30]. p. 19-33. Available from: http://www.sciencedirect.com/science/article/pii/B9780123942951000020.
4. Srinivasan S, Alexander JF, Driessen WH, Leonard F, Ye H, Liu X, et al. Bacteriophage associated silicon particles: design and characterization of a novel theranostic vector with improved payload carrying potential. J Mater Chem B 2013;1:5218.
5. Schopf L, Enlow E, Popov A, Bourassa J, Chen H. Ocular Pharmacokinetics of a Novel Loteprednol Etabonate 0.4% Ophthalmic Formulation. Ophthalmol Ther [Internet]. 2014 Feb 4 [cited 2014 Oct 30]; Available from: http://link.springer.com/10.1007/s40123-014-0021-z.
6. Henry CJ, Bryan JN. Not lost in translation: how study of diseases in our pets can benefit them and us. Mo Med 2013;110:216-9.
7. Ranieri G, Gadaleta CD, Patruno R, Zizzo N, Daidone MG, Hansson MG, et al. A model of study for human cancer: Spontaneous occurring tumors in dogs. Biological features and translation for new anticancer therapies. Crit Rev Oncol Hematol 2013;88:187-97.
8. Reverchon E. Supercritical antisolvent precipitation of micro- and nano-particles. J Supercrit Fluids 1999;15:1-21.
9. Reverchon E, Adami R, Cardea S, Porta GD. Supercritical fluids processing of polymers for pharmaceutical and medical applications. J Supercrit Fluids 2009;47:484-92.
10. Reverchon E, Adami R. Nanomaterials and supercritical fluids. J Supercrit Fluids 2006;37:1-22.
11. Kannan R, Zambre A, Chanda N, Kulkarni R, Shukla R, Katti K, et al. Functionalized radioactive gold nanoparticles in tumor therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2012;4:42-51.
12. Shukla R, Chanda N, Zambre A, Upendran A, Katti K, Kulkarni RR, et al. Laminin receptor specific therapeutic gold nanoparticles (198AuNP-EGCg) show efficacy in treating prostate cancer. Proc Natl Acad Sci USA 2012;109:12426-31.
13. Reddy LH, Couvreur P. Squalene: A natural triterpene for use in disease management and therapy. Adv Drug Deliv Rev 2009;61:1412-26.
14. Maksimenko A, Mougin J, Mura S, Sliwinski E, Lepeltier E, Bourgaux C, et al. Polyisoprenoyl gemcitabine conjugates self assemble as nanoparticles, useful for cancer therapy. Cancer Lett 2013;334:346-53.
15. Valetti S, Maione F, Mura S, Stella B, Desmaële D, Noiray M, et al. Peptide-functionalized nanoparticles for selective targeting of pancreatic tumor. J Controlled Release 2014;192:29-39.
16. Pinier M, Verdu EF, Nasser-Eddine M, David CS, Vézina A, Rivard N, et al. Polymeric Binders Suppress Gliadin-Induced Toxicity in the Intestinal Epithelium. Gastroenterology 2009;136: 288-98.
17. Pinier M, Fuhrmann G, Galipeau HJ, Rivard N, Murray JA, David CS, et al. The Copolymer P(HEMA-co-SS) Binds Gluten and Reduces Immune Response in Gluten-Sensitized Mice and Human Tissues. Gastroenterology 2012;142:316-25.e12.
18. Venditto VJ, Szoka FC. Cancer Nanomedicines: So Many Papers and So Few Drugs! Adv Drug Deliv Rev 2013;65:80-8.
19. Viagra, an accidental drug story. BBC [Internet]. 2010 Jan 20 [cited 2014 Oct 30]; Available from: http://news.bbc.co.uk/2/hi/health/8466118.stm.